Charles River Laboratories | CRL - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
Agilent USD 608M 7M 2026-06
Align Technology USD 109.84M 13.88M 2026-06
Bio-Rad Laboratories USD 143.5M 10.4M 2026-06
Bruker USD 200.2M 68.9M 2026-06
Cardinal Health USD 38.28B 449M 2026-06
Charles River Laboratories USD 140.98M 7.03M 2026-06
Cigna USD 10.41B 530M 2026-06
Concord Medical Services Hldg CNY 119.29M 7.1M 2025-12
CVS Health USD 59.68B 1.09B 2026-06
Danaher USD 2.07B 282M 2026-06
Dentsply International USD 260M 1000K 2026-06
Elevance Health USD 6.63B 423M 2026-06
Humana USD 7.26B 732M 2026-06
Illumina USD 230M 12M 2026-06
Incyte USD 1.39B 1.16B 2026-06
Intrexon USD 4.85M 3.12M 2024-06
IQVIA Holdings USD 3.61B 31M 2026-06
Laboratory Of America USD 688.5M 7.2M 2026-06
Lakefront Biotherapeutics EUR 66.35M 29.42M 2026-06
Lonza CHF 471M 3M 2024-12
McKesson USD 63.73B 3.76B 2026-06
Merck EUR 2.07B 61M 2026-06
Mettler Toledo International USD 229.8M 1.08M 2026-06
Novartis USD 4.26B 64M 2026-06
Pfizer USD 4.58B 75M 2026-06
Quest Diagnostics USD 1.6B 98M 2026-06
Revvity USD 165.74M 3.94M 2026-06
Thermo Fisher Scientific USD 3.34B 278M 2026-03
United Therapeutics USD 497.8M 500K 2026-06
UnitedHealth USD 78.29B 921M 2026-03
Veradigm USD 30.84M 18.23M 2022-12
Waters USD 602M 498.22M 2026-03
West Pharmaceutical Services USD 252.7M 400K 2026-06